ETOPOSIDE

Etoposide is a topoisomerase II inhibitor causing DNA strand breaks, used in various cancers. Side effects include myelosuppression, hair loss, and nausea.

SKU: 8cb642a02f9b Category: Tag:

Product Description


Mechanism of Action

Etoposide is a topoisomerase II inhibitor that stabilizes the DNA–topoisomerase II cleavage complex, leading to double‑strand DNA breaks and apoptosis in rapidly dividing cells. It is semisynthetic, derived from podophyllotoxin.

Benefits and Advantages

Used in DNA‑damage research, topoisomerase‑II inhibition assays, oncologic‑model development, and cytotoxicity pathway studies.

Side Effects and Risks

Risks include myelosuppression, alopecia, mucositis, hypotension (IV), and secondary malignancies. Handle with cytotoxic‑topoisomerase‑inhibitor precautions.

Datasheet


Molecular Formula

C29H32O13

Molecular Weight

588.6 g/mol

CAS Number

33419-42-0

Storage Condition

Etoposide concentrate for injection should be stored at room temperature.

Solubility

Sparingly soluble

Purity

Purity information is available upon request (COA).

Synonym

etoposide; VePesid; 33419-42-0; Toposar; trans-Etoposide

IUPAC/Chemical Name

(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one

InChl Key

VJJPUSNTGOMMGY-MRVIYFEKSA-N

InChl Code

InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/36462;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download